Motif Bio (MTFB): Remain positive on REVIVE-2 readout (BUY) | LiDCO* (LID): US FDA approves latest monitor (CORP) | Zambeef* (ZAM): Still not firing on all cylinders (CORP) | Cambridge Cognition* (COG): Speech recognition clinical trial software (CORP) | Water Intelligence* (WATR): locking in growth potential (CORP) | Shoe Zone (SHOE): Disappointing H1 (HOLD) | Minds + Machines* (MMX): Valuing renewals (CORP) | Intercede* (IGP): Prelims on track (CORP)

07 Jun 2017
Morning Note

Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Morning Note
- Published:
07 Jun 2017 -
Author:
Andrew Darley | Guy Hewett | Mark Brewer | Cavendish Research -
Pages:
11 -
Motif Bio (MTFB): Remain positive on REVIVE-2 readout (BUY) | LiDCO* (LID): US FDA approves latest monitor (CORP) | Zambeef* (ZAM): Still not firing on all cylinders (CORP) | Cambridge Cognition* (COG): Speech recognition clinical trial software (CORP) | Water Intelligence* (WATR): locking in growth potential (CORP) | Shoe Zone (SHOE): Disappointing H1 (HOLD) | Minds + Machines* (MMX): Valuing renewals (CORP) | Intercede* (IGP): Prelims on track (CORP)